Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Sir Richard Sykes Appointed Chair of Vaccine Taskforce
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant […]
Dr. Paul Burton to Join Moderna as Chief Medical Officer
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today […]
Startup Hertility Health Raises £4.2M in Seed Funding to Help Reduce Diagnosis Time of Most Common Reproductive Issues
Hertility Health, the new women’s health start-up revolutionising the world of hormone and reproductive health, […]
TailorMed Fuels Further Growth with a $20 Million Financing, Led by Providence Ventures
TailorMed Medical Ltd., a leading patient financial navigation technology company that helps healthcare patients remove […]
GENinCode Announces Major US Commercialisation Partnership with EVERSANA
GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure
Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it […]
Medixine Raises €2.9M Funding to Help Healthcare Providers Offer Comprehensive Remote Care Services
The Finland-based telehealth provider Medixine has raised €2.9 million in funding led by a crowdfunding […]
NIIMBL Announces $4.6M to Fund 10 New Biopharmaceutical Manufacturing Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for […]
Tata Digital to Acquire Majority Stake in India’s Leading Online Healthcare Marketplace 1MG
Tata Digital Limited, a 100% subsidiary of Tata Sons Private Limited, will acquire a majority […]
ViAqua Therapeutics Announces $4.3 Million Investment for RNA-based Aquaculture Health Platform
ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more